1/45
A comprehensive vocabulary review of T-cell biology, detailing developmental checkpoints in the thymus, receptor rearrangement, positive and negative selection, homing mechanisms, activation signaling, and CD4/CD8 effector subsets.
Thymus
The primary lymphoid organ located in the upper anterior thorax above the heart where immature T cells develop, undergo TCR gene rearrangement, and are subjected to positive and negative selection.
Thymocytes
Developing, immature T lymphocytes that originate from bone marrow stem cells and undergo differentiation while embedded within the thymic epithelial stroma.
Thymic Stroma
The extensive, supporting network of epithelial cells in the cortex and medulla of the thymus that provides physical structure and essential survival signals to developing thymocytes.
Hassall's Corpuscles
Concentric, layered corpuscular structures characteristic of the thymic medulla that are hypothesized to represent sites of thymocyte destruction.
Uncommitted Progenitor Cell
A stem-cell-derived T-cell precursor arriving at the thymus from the blood that expresses the stem-cell markers CD34 and CD44 and retains germline TCR genes.
Double-Negative (DN) Thymocytes
Developing thymocytes that have committed to the T-cell lineage (expressing CD2 and CD5) but have not yet expressed either the CD4 or CD8 co-receptors.
Notch1
A cell-surface signaling receptor on developing thymocytes that engages thymic epithelial ligands to drive T-cell lineage specification and prevent the rearrangement of B-cell receptor genes.
Pre-T-Cell Receptor (Pre-TCR)
A temporary receptor complex assembled on double-negative thymocytes consisting of a productively rearranged TCR β chain paired with the invariant surrogate α chain (pTtau), along with the CD3 signaling complex and ζ chains.

pTα (Surrogate α Chain)
An invariant surrogate protein that pairs with a newly translated TCR β chain during checkpoint 1 of T-cell development to test the structural integrity of the β chain.
Allelic Exclusion (β-Chain Locus)
The repression of RAG−1 and RAG−2 expression following successful pre-TCR assembly that halts further rearrangements at the TCR β locus, ensuring each T cell expresses only one unique β-chain specificity.
Double-Positive (DP) Thymocytes
Immature thymocytes situated primarily within the thymic cortex that express both CD4 and CD8 co-receptors alongside a complete T-cell receptor complex.
Positive Selection
The developmental screening process in the thymic cortex mediated by cortical epithelial cells where double-positive thymocytes are tested for moderate binding to self-MHC class I and class II molecules to establish self-MHC restriction.
Cortical Thymic Epithelial Cells (cTECs)
Epithelial stroma cells of the thymic cortex that display self-peptides on MHC class I and class II molecules to deliver crucial survival signals to double-positive thymocytes during positive selection.
Single-Positive Thymocytes
Mature thymocytes that have successfully undergone positive selection and committed to a single co-receptor lineage, becoming either CD4+ (MHC class II-restricted) or CD8+ (MHC class I-restricted).
δ-Chain Locus Deletion
The permanent excision and elimination of the TCR δ gene segment locus from the chromosome that inherently occurs during the somatic recombination of the encompassing TCR α chain.

Negative Selection
The screening process in the cortico-medullary junction and medulla mediated by bone marrow-derived dendritic cells and macrophages that induces apoptosis in thymocytes whose TCRs bind self-peptide:self-MHC complexes with high affinity.
Central Tolerance
The immunological non-responsiveness to self-antigens established within primary lymphoid organs (the thymus for T cells) through the clonal deletion of autoreactive lymphocytes.
AIRE (Autoimmune Regulator)
A transcriptional regulator expressed by medullary thymic epithelial cells that promotes the ectopic expression of peripheral tissue-specific proteins in the thymus to facilitate negative selection against self-antigens.
DiGeorge Syndrome
A congenital disorder caused by a microdeletion on chromosome 22 that prevents normal thymic development, resulting in an absence of mature T cells and extreme vulnerability to opportunistic infections resembling SCID.
Thymic Involution
The age-dependent shrinkage and functional atrophy of the thymus, characterized by the progressive replacement of productive lymphoid tissue with fat without compromising established peripheral T-cell immunity.
Regulatory T Cells (Treg)
A specialized subset of CD4 effector T cells that expresses the master transcriptional repressor FoxP3 and cell-surface CD25 to suppress the proliferation of autoreactive T cells interacting with the same APC.

T-Cell Priming (T-Cell Activation)
The initial antigen-dependent stimulation and clonal expansion of a mature naïve T cell upon first encountering its cognate peptide:MHC complex presented by a professional APC in secondary lymphoid tissue.
Langerhans Cells
Immature dendritic cells resident in the epidermis and peripheral tissues that specialize in antigen uptake through macropinocytosis and DEC205-mediated endocytosis prior to activation.
Interdigitating Reticular Cells
Mature, activated dendritic cells that localize in the T-cell cortex of secondary lymphoid tissues, characterized by dendritic projections, high levels of B7 and MHC molecules, and expression of DC-SIGN.
High Endothelial Venules (HEVs)
Specialized post-capillary venules lined by tall endothelial cells within lymph node cortices through which circulating naïve lymphocytes extravasate from the bloodstream into secondary lymphoid tissue.
L-Selectin (CD62L)
An adhesion lectin on naïve T cells that binds sulfated carbohydrate sialyl-Lewisx residues on vascular addressins (CD34 and GlyCAM-1) to initiate rolling adhesion along HEVs.
CCR7
The chemokine receptor expressed on naïve T cells and mature dendritic cells that binds the chemokines CCL19 and CCL21 to guide cellular entry and positioning in lymph node T-cell areas.
Sphingosine 1-Phosphate (S1P)
A lipid chemotactic mediator whose gradient draws naïve T cells that have failed to recognize an antigen out of the lymph node cortex and into the efferent lymphatic circulation.
Extravasation
The four-step transendothelial migration process by which circulating lymphocytes exit HEVs into lymphoid tissue: rolling adhesion, tight binding, diapedesis, and migration.
B7 Molecules (B7.1/CD80 and B7.2/CD86)
Co-stimulatory cell-surface glycoproteins expressed on professional APCs in response to infection that interact with CD28 on naïve T cells to provide essential activation signal 2.
CD28
A co-stimulatory receptor constitutively expressed on naïve T cells that binds B7 molecules on professional APCs, delivering intracellular signals that stabilize IL−2 mRNA and drive clonal expansion.
CTLA-4 (CD152)
An inhibitory receptor upregulated on activated T cells that binds B7 with twentyfold higher affinity than CD28, delivering signals that attenuate activation and limit lymphocyte proliferation.
T-Cell Anergy
A sustained state of metabolic non-responsiveness induced when a mature naïve T cell encounters specific peptide:MHC complexes in the absence of co-stimulatory B7 signaling, establishing peripheral tolerance.
Supramolecular Activation Complex (SMAC)
The organized multiprotein assembly forming the immunological synapse between a T cell and an APC, divided into a central zone (c-SMAC) containing TCRs and signaling molecules and a peripheral zone (p-SMAC) containing adhesion proteins like LFA-1.

ITAMs (Immunoreceptor Tyrosine-based Activation Motifs)
Conserved tyrosine-containing motifs on the cytoplasmic tails of CD3 subunits and ζ chains that are phosphorylated by Lck upon TCR engagement, creating docking sites for ZAP-70.
ZAP-70
A cytoplasmic protein tyrosine kinase that binds phosphorylated ITAMs on the ζ chain of the TCR complex and is phosphorylated by Lck, initiating downstream activation of PLC-γ.
High-Affinity IL-2 Receptor
A heterotrimeric receptor complex consisting of α (CD25), β, and γ chains synthesized by activated T cells to capture autocrine and paracrine IL−2 with high affinity and drive rapid clonal proliferation.

VLA-4 (α4β1 Integrin)
An integrin expressed on activated effector T cells that binds VCAM-1 on inflamed vascular endothelium, directing the homing of effector cells away from lymph nodes and toward sites of infection.
TH1 Cell
A CD4 effector T-cell subset driven by transcription factor T-bet in response to IL−12 and IFN-γ that secretes IFN-γ and lymphotoxin to activate macrophages against intracellular pathogens.
TH2 Cell
A CD4 effector T-cell subset driven by transcription factor GATA3 in response to IL−4 that secretes IL−4, IL−5, and IL−13 to coordinate immune defenses against helminth parasites and stimulate IgE synthesis.
Lepromatous vs. Tuberculoid Leprosy Cytokine Pattern
The polarized immune profiles seen in Mycobacterium leprae infection: tuberculoid leprosy displays a protective TH1 response (IL−2, IFN-γ), while lepromatous leprosy displays a non-protective TH2 profile (IL−4, IL−5, IL−10) resulting in florid bacterial growth.

TH17 Cell
A CD4 effector T-cell subset induced by IL−6 and TGF-β via the transcription factor RORγT that produces IL−17 and IL−22 to recruit and activate neutrophils against extracellular bacteria and fungi.
TFH Cell (T Follicular Helper)
A CD4 effector T-cell subset driven by transcription factor Bcl-6 that expresses CXCR5 to enter B-cell follicles, secreting IL−21 and expressing CD40L to direct B-cell proliferation, affinity maturation, and isotype switching.
Cytotoxins (CD8 T Cells)
Preformed, specialized proteins stored in lytic granules of cytotoxic CD8 T cells—including perforin, granzymes, granulysin, and serglycin—released directly onto target cells to program them for apoptotic death.
JAK-STAT Signaling Pathway
The intracellular signaling cascade where cytokine binding causes receptor dimerization, activating Janus kinases (JAKs) to phosphorylate STAT proteins that dimerize and enter the nucleus to initiate transcription.

Cognate Interaction
A linked immunological collaboration between an antigen-specific B cell and a TFH cell where both cells recognize distinct epitopes derived from the exact same macromolecular antigen.